Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-01

Clinical Trial Update: Monotherapy With Levetiracetam in Patients Suffering From Epilepsy. [Phase 3]

View source ↗

Summary

A Phase 3 monotherapy trial of levetiracetam in epilepsy patients has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma SA | Conditions: Epilepsy, Tonic-clonic | Phase 3 | Status: COMPLETED | Results posted: 2018-10-01